BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16723155)

  • 21. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The indoor air pollutant 2-ethyl-hexanol activates CD4 cells.
    Yoshida Y; Liu J; Sugiura T; Ishidao T; Ueno S; Yanagita H; Fueta Y; Kunugita N; Hori H; Yamashita U
    Chem Biol Interact; 2009 Jan; 177(2):137-41. PubMed ID: 19038237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes.
    Ferrari-Lacraz S; Chicheportiche R; Schneiter G; Molnarfi N; Villard J; Dayer JM
    Int Immunol; 2008 Aug; 20(8):1009-18. PubMed ID: 18556671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
    Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
    Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Priming of CD4+ T cells with porin of Shigella dysenteriae activates the cells toward type 1 polarization.
    Biswas A; Banerjee P; Biswas T
    Int Immunol; 2008 Jan; 20(1):81-8. PubMed ID: 18003602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
    Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C theta plays a fundamental role in different types of chronic colitis.
    Nagahama K; Ogawa A; Shirane K; Shimomura Y; Sugimoto K; Mizoguchi A
    Gastroenterology; 2008 Feb; 134(2):459-69. PubMed ID: 18155708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
    Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F
    Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttranscriptional mechanisms of glucocorticoid antiproliferative effects: glucocorticoids inhibit IL-6-induced proliferation of B9 hybridoma cells.
    Almawi WY; Tamim H
    Cell Transplant; 2001; 10(2):161-4. PubMed ID: 11332630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of koumine on proliferation of murine CD4+ T cells purified by magnetic-activated cell sorting in vitro].
    Wang ZR; Huang CQ; Zhang ZY; Zhang LL; Lin JM
    Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):562-4. PubMed ID: 15897137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of Angelica sinensis polysaccharide on cell-mediated immunity].
    Yang TH; Jia M; Mei QB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):782-3, 788. PubMed ID: 16256045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune suppression via glucocorticoid-stimulated monocytes: a novel mechanism to cope with inflammation.
    Varga G; Ehrchen J; Brockhausen A; Weinhage T; Nippe N; Belz M; Tsianakas A; Ross M; Bettenworth D; Spieker T; Wolf M; Lippe R; Tenbrock K; Leenen PJ; Roth J; Sunderkötter C
    J Immunol; 2014 Aug; 193(3):1090-9. PubMed ID: 24990080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment with glucocorticoids enhances T-cell effector function: possible implication for immune rebound accompanying glucocorticoid withdrawal.
    Almawi WY; Hess DA; Assi JW; Chudzik DM; Rieder MJ
    Cell Transplant; 1999; 8(6):637-47. PubMed ID: 10701493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The kaleidoscope of glucorticoid effects on immune system.
    Zen M; Canova M; Campana C; Bettio S; Nalotto L; Rampudda M; Ramonda R; Iaccarino L; Doria A
    Autoimmun Rev; 2011 Apr; 10(6):305-10. PubMed ID: 21224015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoid regulation of the inflammatory response to injury.
    Yeager MP; Guyre PM; Munck AU
    Acta Anaesthesiol Scand; 2004 Aug; 48(7):799-813. PubMed ID: 15242423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the Impact from IL-2, IL-7, and IL-15 on the Growth and Signaling of Activated CD4
    Coppola C; Hopkins B; Huhn S; Du Z; Huang Z; Kelly WJ
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of IL-2 production and proliferation of CD4(+) T cells by tuberostemonine O.
    Jung Jang E; Kil YS; Ryeon Park H; Oh S; Kyeong Kim H; Gyeong Jeong M; Kyoung Seo E; Sook Hwang E
    Chem Biodivers; 2014 Dec; 11(12):1954-62. PubMed ID: 25491339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutting Edge: Limiting amounts of IL-7 do not control contraction of CD4+ T cell responses.
    Tripathi P; Mitchell TC; Finkelman F; Hildeman DA
    J Immunol; 2007 Apr; 178(7):4027-31. PubMed ID: 17371956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-associated decline in responses of naïve T cells to in vitro immunization reflects shift in glucocorticoid sensitivity.
    Dozmorov IM; Miller RA
    Life Sci; 1999; 64(20):1849-59. PubMed ID: 10350359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.